TOLBUTAMIDE Drug Patent Profile
✉ Email this page to a colleague
When do Tolbutamide patents expire, and what generic alternatives are available?
Tolbutamide is a drug marketed by Alra, Ani Pharms, Ascot, Barr, Chartwell Rx, Dava Pharms Inc, Mylan Pharms Inc, Parke Davis, Purepac Pharm, Sandoz, Superpharm, Vangard, and Watson Labs. and is included in sixteen NDAs.
The generic ingredient in TOLBUTAMIDE is tolbutamide. There are fifteen drug master file entries for this compound. Additional details are available on the tolbutamide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TOLBUTAMIDE?
- What are the global sales for TOLBUTAMIDE?
- What is Average Wholesale Price for TOLBUTAMIDE?
Summary for TOLBUTAMIDE
US Patents: | 0 |
Applicants: | 13 |
NDAs: | 16 |
Raw Ingredient (Bulk) Api Vendors: | 121 |
Clinical Trials: | 30 |
Patent Applications: | 3,303 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TOLBUTAMIDE at DailyMed |
![TOLBUTAMIDE drug patent expirations Drug patent expirations by year for TOLBUTAMIDE](/p/graph/s/t/TOLBUTAMIDE-patent-expirations.png)
Recent Clinical Trials for TOLBUTAMIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Pfizer | Phase 1 |
Radboud University | Phase 1 |
Oregon State University | Phase 1 |
Medical Subject Heading (MeSH) Categories for TOLBUTAMIDE
Anatomical Therapeutic Chemical (ATC) Classes for TOLBUTAMIDE
US Patents and Regulatory Information for TOLBUTAMIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alra | TOLBUTAMIDE | tolbutamide | TABLET;ORAL | 086141-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Mylan Pharms Inc | TOLBUTAMIDE | tolbutamide | TABLET;ORAL | 086445-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Barr | TOLBUTAMIDE | tolbutamide | TABLET;ORAL | 087121-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Vangard | TOLBUTAMIDE | tolbutamide | TABLET;ORAL | 087876-001 | Apr 20, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Parke Davis | TOLBUTAMIDE | tolbutamide | TABLET;ORAL | 086047-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Watson Labs | TOLBUTAMIDE | tolbutamide | TABLET;ORAL | 089111-001 | May 29, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |